| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/06/1999 | EP0913474A2 Dbpa, a helicase from Staphylococcus aureus |
| 05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
| 05/06/1999 | EP0912895A1 Method for monitoring t-cell reactivity |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines |
| 05/06/1999 | EP0912601A1 Suppression of immune response via inhibition of cathepsin s |
| 05/06/1999 | EP0912519A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors |
| 05/06/1999 | EP0912515A1 1,4-di-sustituted piperidines as muscarinic antagonists |
| 05/06/1999 | EP0912189A1 Use of artichoke (cynara) extracts |
| 05/06/1999 | EP0912186A1 Progestogen-anti-progestogen regimens |
| 05/06/1999 | EP0912182A1 Fibrinogen receptor antagonist prodrugs |
| 05/06/1999 | EP0912178A1 Methods of treating hypertension |
| 05/06/1999 | EP0912174A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 05/06/1999 | EP0912167A1 Granulates of hexahydropyrazine derivatives which can be administered orally |
| 05/06/1999 | EP0912097A1 Antimicrobial peroxidase compositions |
| 05/06/1999 | EP0912091A1 Use of gaba uptake inhibitors as anti-tussive agents |
| 05/06/1999 | EP0912086A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 05/06/1999 | EP0912085A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 05/06/1999 | EP0667911B1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | EP0563060B1 Use of IL-4 and TNF for the preparation of a medicament for the treatment of tumour cells |
| 05/06/1999 | EP0550702B1 METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2? |
| 05/06/1999 | DE19748763A1 Verwendung von Vasopressin-Antagonisten Use of vasopressin antagonists |
| 05/06/1999 | CA2308453A1 Method of reducing craving in mammals |
| 05/06/1999 | CA2307826A1 Enhancement of morphogen activity |
| 05/06/1999 | CA2306817A1 Treatment of schizophrenia with ampakines and neuroleptics |
| 05/06/1999 | CA2306790A1 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/06/1999 | CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | CA2305349A1 Methods and pharmaceutical compositions for the closure of retinal breaks |
| 05/06/1999 | CA2305293A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 05/05/1999 | CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 05/05/1999 | CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate |
| 05/05/1999 | CN1043189C Method for preparing prolonged release preparation |
| 05/04/1999 | US5900435 Liquid food |
| 05/04/1999 | US5900429 Treating breast cancer in mammals by administering taxol or cisplatin to reduce tumor or cancer, then administering 2-methoxycarbonylaminobenzimidazole or pharmaceutical addition salts; anticarcinogenic/antitumor agents |
| 05/04/1999 | US5900421 Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
| 05/04/1999 | US5900407 Method of treating dry eye disease with uridine triphosphates and related compounds |
| 05/04/1999 | US5900360 Screening protein stabilizing agents (not congo red) by incubating cell containing conformationally defective protein, determining effective concentration to improve phenotype; treatment of cystic fibrosis, scrapie |
| 05/04/1999 | US5900252 Multidose minitablet drug cores surrounded by a first polymeric membrane soluble at ph above 5.5 and an outer insoluble membrane which is permeable to gastric fluids, for timed release in ileum or colon |
| 05/04/1999 | US5900249 A vasodilator, a non-steroidal anti-inflammatory drug, a membrane stabilizer, and a seratogenic and nonadrenergic reuptake inhibitor, and additionally a medically acceptable carrier into which the foregoing are incorporated. |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | CA2078129C O6-benzylated guanine, guanosine and 2'- deoxyguanosine compounds possessing o6-alkylguanine-dna alkyltransferase depleting activity |
| 04/30/1999 | CA2248996A1 Novel ornithine carbamoyltransferase |
| 04/30/1999 | CA2219867A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 04/29/1999 | WO1999020794A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors |
| 04/29/1999 | WO1999020791A1 Method for suppressing multiple drug resistance in cancer cells |
| 04/29/1999 | WO1999020758A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 04/29/1999 | WO1999020310A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | WO1999020307A1 NOVEL pheS (BETA) |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020297A1 Prevention and treatment of adhesion formation |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020284A1 Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents |
| 04/29/1999 | WO1999020280A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | WO1999020279A1 Potentiation of pharmaceuticals |
| 04/29/1999 | WO1999020267A1 Furanyl, tetracyclic triterpene derivatives with immunosuppressant activity |
| 04/29/1999 | WO1999020264A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 04/29/1999 | WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020251A1 Use of inhaled no as anti-inflammatory agent |
| 04/29/1999 | WO1999020250A1 Topical antifungal composition |
| 04/29/1999 | WO1999020242A1 Compositions based on plant extracts |
| 04/29/1999 | WO1999020223A2 Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive |
| 04/29/1999 | WO1999020110A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | WO1999007354A3 Compositions, apparatus and methods for facilitating surgical procedures |
| 04/29/1999 | WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 04/29/1999 | WO1999006033A3 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1998042296A9 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 04/29/1999 | DE19746868A1 Use of tumour necrosis factor antagonists |
| 04/29/1999 | CA2308114A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods |
| 04/29/1999 | CA2307342A1 Method for suppressing multiple drug resistance in cancer cells |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2306985A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | CA2306646A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | CA2306445A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immunoreceptors |
| 04/29/1999 | CA2306414A1 Compositions based on plant extracts |
| 04/29/1999 | CA2306233A1 Potentiation of pharmaceuticals |
| 04/29/1999 | CA2306204A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911405A2 Gapdh |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911342A1 Novel protein and process for producing the same |
| 04/28/1999 | EP0911321A2 Compounds for the treatment of osteoporosis |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |